These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2872611)

  • 1. Effects of N-allylnormetazocine (SKF 10,047), phencyclidine, and other psychomotor stimulants in the rat following 6-hydroxydopamine lesion of the ventral tegmental area.
    French ED
    Neuropharmacology; 1986 Apr; 25(4):447-50. PubMed ID: 2872611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phencyclidine-induced locomotor activity in the rat is blocked by 6-hydroxydopamine lesion of the nucleus accumbens: comparisons to other psychomotor stimulants.
    French ED; Vantini G
    Psychopharmacology (Berl); 1984; 82(1-2):83-8. PubMed ID: 6141586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phencyclidine binding sites in the nucleus accumbens and phencyclidine-induced hyperactivity are decreased following lesions of the mesolimbic dopamine system.
    French ED; Pilapil C; Quirion R
    Eur J Pharmacol; 1985 Oct; 116(1-2):1-9. PubMed ID: 2996909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amphetamine-, scopolamine- and caffeine-induced locomotor activity following 6-hydroxydopamine lesions of the mesolimbic dopamine system.
    Joyce EM; Koob GF
    Psychopharmacology (Berl); 1981; 73(4):311-3. PubMed ID: 6789349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of ventral tegmental 6-hydroxydopamine lesions on the locomotor stimulant action of nicotine in rats.
    Louis M; Clarke PB
    Neuropharmacology; 1998 Dec; 37(12):1503-13. PubMed ID: 9886673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional recovery following transplantation of ventral mesencephalic cells in rat subjected to 6-OHDA lesions of the mesolimbic dopaminergic neurons.
    Nadaud D; Herman JP; Simon H; Le Moal M
    Brain Res; 1984 Jun; 304(1):137-41. PubMed ID: 6331577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperactivity and hypoactivity produced by lesions to the mesolimbic dopamine system.
    Koob GF; Stinus L; Le Moal M
    Behav Brain Res; 1981 Nov; 3(3):341-59. PubMed ID: 6796098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of competitive N-methyl-D-aspartate antagonists on midbrain dopamine neurons: an electrophysiological and behavioral comparison to phencyclidine.
    French ED; Ferkany J; Abreu M; Levenson S
    Neuropharmacology; 1991 Oct; 30(10):1039-46. PubMed ID: 1836840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavioral and neurochemical effects of neurotensin microinjection into the ventral tegmental area of the rat.
    Kalivas PW; Burgess SK; Nemeroff CB; Prange AJ
    Neuroscience; 1983 Mar; 8(3):495-505. PubMed ID: 6406930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of mesolimbic dopamine in conditioned locomotion produced by amphetamine.
    Gold LH; Swerdlow NR; Koob GF
    Behav Neurosci; 1988 Aug; 102(4):544-52. PubMed ID: 3139012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of 6-hydroxydopamine-induced lesions of A10 dopaminergic neurons on aggressive behavior in rats.
    Puciłowski O; Kostowski W; Bidziński A; Hauptmann M
    Pharmacol Biochem Behav; 1982 Apr; 16(4):547-51. PubMed ID: 6803251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of phencyclidine and N-allylnormetazocine on midbrain dopamine neuronal activity.
    Freeman AS; Bunney BS
    Eur J Pharmacol; 1984 Sep; 104(3-4):287-93. PubMed ID: 6094217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of injections of 6-OHDA into either nucleus accumbens septi or frontal cortex on spontaneous and drug-induced activity.
    Joyce EM; Stinus L; Iversen SD
    Neuropharmacology; 1983 Sep; 22(9):1141-5. PubMed ID: 6415508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesolimbic dopamine lesions produce an augmented behavioral response to enkephalin.
    Kalivas PW; Bronson M
    Neuropharmacology; 1985 Oct; 24(10):931-6. PubMed ID: 3934576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine-rich transplants in rats with 6-OHDA lesions of the ventral tegmental area. I. Effects on spontaneous and drug-induced locomotor activity.
    Dunnett SB; Bunch ST; Gage FH; Björklund A
    Behav Brain Res; 1984 Jul; 13(1):71-82. PubMed ID: 6477720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phencyclidine-induced stereotyped behaviors after injection of morphine and N-allylnormetazocine (SKF 10,047) in rats.
    Nabeshima T; Hiramatsu M; Kameyama T
    Pharmacol Biochem Behav; 1986 Jun; 24(6):1629-34. PubMed ID: 3016758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of the A10 mesolimbic system by the sigma-receptor agonist (+)SKF 10,047 can be blocked by rimcazole, a novel putative antipsychotic.
    Ceci A; Smith M; French ED
    Eur J Pharmacol; 1988 Sep; 154(1):53-7. PubMed ID: 2903063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between the discharge rate of non-dopamine neurons in substantia nigra and ventral tegmental area and the motor activity induced by apomorphine.
    Olds ME
    Neuroscience; 1988 Feb; 24(2):465-76. PubMed ID: 3362349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Injections of 6-hydroxydopamine into the ventral tegmental area destroy mesolimbic dopamine neurons but spare the locomotor activating effects of nicotine in the rat.
    Vezina P; Hervé D; Glowinski J; Tassin JP
    Neurosci Lett; 1994 Feb; 168(1-2):111-4. PubMed ID: 8028761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disruption of cocaine self-administration following 6-hydroxydopamine lesions of the ventral tegmental area in rats.
    Roberts DC; Koob GF
    Pharmacol Biochem Behav; 1982 Nov; 17(5):901-4. PubMed ID: 6817350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.